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1Abstract
Purpose: Induced pluripotent stem (iPS) cells generally exhibit a normal karyotype,
are transcriptionally and epigenetically similar to embryonic stem (ES) cells and
maintain the potential to differentiate into derivatives of all germ layers. Recently, the
use of different types of cell or tissue derived from iPS cells for transplantation has
become a possibility. However, the differentiation of epithelial lineages from iPS cells
has not yet been demonstrated. In this study, we attempted to establish a culture
technique for the induction of stratified epithelial stem/progenitor cells from mouse iPS
cells.
Methods: Mouse iPS cells were cultured on dishes coated with type IV collagen in
keratinocyte culture medium supplemented with or without bone morphogenic
protein-4 and retinoic acid. Markers for undifferentiated cells (Oct3/4, Nanog) and for
differentiation (p63, cytokeratin14, cytokeratin18) were analyzed by
immunofluorescence staining and real-time RT-PCR.
Results: Stratified epithelial stem/progenitor cells were successfully induced in vitro
from mouse iPS cells. These progenitors expressed p63, which is a transcription
factor necessary for maintenance of regenerative epithelia, and cytokeratin14, which
is constitutively present in the basal layer of stratified epithelia. Enhancement of
2stratified epithelial stem/progenitor cell commitment was observed when bone
morphogenic protein-4 and retinoic acid were added to the culture media. The
differentiation efficiency of stratified epithelial stem/progenitor cells from mouse iPS
cell cultures was similar to that of mouse ES cell cultures.
Conclusions: This report is the first to demonstrate the in vitro differentiation of iPS
cells into stratified epithelial stem/progenitor cells. These iPS-derived stratified
epithelial stem/progenitor cells provide a powerful tool for understanding the
mechanisms of epithelial lineage differentiation.
3Background
In recent years, tissue engineering using somatic stem cells has become a
second-generation therapeutic method. However, the key to making tissue
reconstruction possible is the existence of a sufficient stem cell source.
Embryonic stem (ES) cells derived from the inner cell mass of mammalian
blastocysts are pluripotent cells capable of differentiating into any cell type of the
body.1) Unfortunately, the use of human embryos as a source of ES cells faces ethical
and clinical controversies that hinder this practice. One way to circumvent these
issues is to induce a pluripotent status in somatic cells by direct reprogramming.2)
Yamanaka et al. showed that induced pluripotent stem (iPS) cells can be generated
from mouse embryonic fibroblasts and adult mouse tail-tip fibroblasts by
retrovirus-mediated transfection of four transcription factors, namely Oct3/4, Sox2,
c-Myc, and Klf4.3), 4) Furthermore, they demonstrated generation of iPS cells from
adult human dermal fibroblasts with the same four factors.5)
Recent studies have reported that mouse and human iPS cells can differentiate into
specific cell types, such as hematopoietic cells, cardiomyocytes, vascular cells, motor
neurons, and insulin-producing cells, under appropriate conditions.6)-12) However, iPS
cell differentiation toward epithelial lineages has not yet been demonstrated.
4Purpose
In the present study, we examined the epithelial differentiation potential of iPS cells.
In addition, we demonstrated a new strategy for generating stratified epithelial
stem/progenitor cells from mouse iPS cells in vitro. This work not only contributes to
our understanding of the mechanisms of epithelial lineage differentiation but also
facilitates the clinical application of patient-specific iPS cells for novel therapeutic
strategies.
5Materials and Methods
Cell Culture
The mouse ES cell line RF8 and the iPS cell line Nanog-iPS (iPS-MEF-Ng-38D-2),
which were used in all experiments, were provided by Dr. Robert Farese, Jr. at
Gladstone Institute and Dr. Yamanaka at Kyoto University, respectively.
RF8 and Nanog-iPS cells were maintained in the presence of a mitomycin C-treated
SNL feeder layer and SNLP feeder layer on gelatin-coated dishes, respectively. SNL
cells were clonally derived from STO cell line and stably express a neomycin
resistance cassette and leukemia inhibitory factor. The SNLP cells were a
puromycin-resistant derivative of SNL cells.13) These feeder cells were provided by Dr.
Allan Bradley at the Trust Sanger Institute.
The culture medium for the RF8 cells consisted of Dulbecco’s modified Eagle’s
medium (DMEM) (Nacalai Tesque, Kyoto, Japan) supplemented with 15% fetal bovine
serum (FBS) (Cosmo Bio, Tokyo, Japan), 2 mM L-glutamine (Invitrogen, Carlsbad,
CA), 10-4 M nonessential amino acids (Invitrogen), 10-4 M 2-mercaptoethanol
(Invitrogen), and 50 U ml-1 penicillin and 50 g ml-1 streptomycin (Invitrogen).5) For
Nanog-iPS culture, puromycin (Sigma-Aldrich, St. Louis, MO) was added to the RF8
culture medium at a final concentration of 1.5 g ml-1.
6Induction of mouse ES and iPS cell differentiation
For induction of stratified epithelial stem/progenitor cell differentiation, 2 x 104 cells
were cultured on type IV collagen-coated 6-well plates in keratinocyte culture medium
(KCM) for 35 days. KCM was supplemented with or without 0.5 nM bone morphogenic
protein-4 (BMP-4) (R&D Systems Inc., Minneapolis) and 1 M retinoic acid (RA)
(Sigma-Aldrich).
KCM consisted of DMEM without glutamine (Invitrogen) and F-12 Nutrient Mixture
(Ham’s F-12) (Invitrogen) supplemented with 5% FBS (Invitrogen), 100 U ml-1
penicillin and 100 g ml-1 streptomycin (Invitrogen), 0.4 mg ml-1 hydrocortisone
succinate (Wako, Osaka, Japan), 2 M 3,3’,5-triiodo-L-thyronine sodium salt (MP
Biomedicals, LLC., Solon, OH, USA ), 10 nM cholera toxin (Cosmo Bio), 2.25 mg ml-1
bovine transferring HOLO form (Invitrogen), 2 mM L-glutamine (Invitrogen), 0.5%
insulin transferrin selenium solution (Invitrogen), and 10 ng ml-1 recombinant human
EGF (R&D Systems Inc).
Immunofluorescence staining
Mouse ES and iPS cells grown on type IV collagen-coated 6-well plates in KCM were
7fixed in precooled methanol at -30°C for 20 min and then incubated with Tris buffered
saline (TBS) (Takara Bio, Shiga, Japan) containing 5% donkey serum and 0.3% Triton
X for 1 hour at room temperature to block non-specific binding sites. They were then
exposed to primary antibodies for 4°C overnight, washed, and exposed to secondary
antibodies. Nuclei were co-stained with Hoechst 33342 (Molecular Probes, Eugene,
OR). The plates were observed by use of a fluorescence microscope (Axiovert 200,
Carl Zeiss, Jena, Germany).
The primary antibodies used for immunofluorescence staining were as follows: goat
polyclonal antibodies raised against p63 (S-16, Santa Cruz Biotechnology Inc., Santa
Cruz, CA) and a rabbit polyclonal antibody raised against cytokeratin (CK) 14 (AF64,
Covance, Richmond, CA). Secondary donkey anti-goat coupled Alexa-Fluor®
antibodies and donkey anti-rabbit coupled Alexa-Fluor® antibodies were purchased
from Invitrogen. The same concentration of corresponding normal IgG were used as
negative controls.
Gene expression analysis
Total RNA was obtained from mouse iPS-cell-derived cells using the RNeasy total
RNA kit (Qiagen, Valencia, CA). Reverse transcription was performed with the
8SuperScript First-Strand Synthesis System for RT-PCR (Invitrogen) according to the
manufacturer’s suggested protocol. The resultant cDNA was used as a template for
PCR. Quantitative real-time RT-PCR was performed using the ABI Prism 7500
Sequence Detection System (Applied Biosystems Inc., Foster City, CA) according to
the manufacturer's suggested protocol. Primer pairs and TaqMan® MGB probes
labeled with 6-carboxyfluorescein (FAM) at the 5’-end and non-fluorescent quencher
at the 3’-end were designed with Assay-by-Design™ (Applied Biosystems).
Thermocycling programs consisted of an initial cycle at 50°C for 2 minutes and 95°C
for 10 minutes and 45 cycles at 95°C for 15 seconds and 60°C for 1 minute. Negative
controls using non-reverse transcribed total RNA as template were performed for all
experiments.
Statistical Analysis
Data are expressed as mean ± SE. Statistical analysis was performed using the
one-way analysis of variance (ANOVA), and significance was set at P < 0.05 or P <
0.001. All statistics were calculated using SigmaStat 3.5 (SPSS, Chicago, IL).
9Results
The experimental design is depicted in Figure 1. Undifferentiated mouse ES and iPS
cells were seeded on type IV collagen-coated 6-well plates and were induced to
differentiate by various methods. Cells were cultured in (A) KCM, (B) KCM with 0.5 nM
BMP-4, or (C) KCM with 0.5 nM BMP-4 and 1 M RA.
Expression of epithelial markers in mouse ES- and iPS-cell-derived cells
In differentiating mouse ES and iPS cells, we detected by day 7 some cells with
nuclei containing p63, a marker for epithelial stem/progenitor cells from various
tissues.14)-16) The number of p63-positive colonies continued to increase for
approximately 21 days. After day 14, p63-positive cells also started to express CK14,
a marker for the stratified epithelial basal layer17) (Fig. 2, N=3). However, on day 14,
we detected a very few cells that clearly expressed CK14 following addition of BMP-4
and RA (Fig. 3A). Because CK14 is a cytoplasmic protein, it was expressed around
the nucleus, where p63 is located. By day 21, cells that were double-positive for p63
and CK14 were observed in all culture conditions. In the instances in which BMP-4 or
BMP-4 combined with RA was added, an earlier appearance and higher levels of p63
and CK14 expression were observed (Fig. 3B). These cells resembled stratified
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epithelial stem/progenitor cells.
Loss of pluripotency and differentiation into epithelial lineages
The loss of mouse ES and iPS cell pluripotency during the differentiation process
was confirmed by real-time RT-PCR analysis (Fig. 4A, 4B, N=3). Real-time RT-PCR
showed that expression of the undifferentiated mouse iPS cell markers Oct3/418) (Fig.
4A-a, 4B-a) and Nanog19), 20) (Fig. 4A-b, 4B-b) declined over the 35 days of
differentiation. These results showed that expression of the pluripotency markers
Oct3/4 and Nanog was downregulated during the differentiation of mouse ES and iPS
cells.
The differentiation of mouse ES and iPS cells into epithelial progenitor cells was
confirmed by real-time RT-PCR analysis (Fig. 4A, 4B, N=3). Real-time RT-PCR
showed that the expression of CK18, a marker for the single-layer ectodermal cells,21)
peaked between day 7 and day 21 then decreased during the following days (Fig.
4A-c, 4B-c). Expression of Np63, a stem cell-specific isoform of p63, increased
progressively after day 7 (Fig. 4A-d, 4B-d). This time course was paralleled by the
percentage of p63-positive colonies detected by immunofluorescence analysis (Fig. 2).
The expression of CK14 increased, following that of Np63 (Fig.4A-e, 4B-e). This
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trend was paralleled by an increase in the percentage of CK14-positive colonies by
immunofluorescence analysis (Fig. 2). These results showed that expression of the
stratified epithelial stem/progenitor markers p63 and CK14 was upregulated during
the differentiation of mouse ES and iPS cells.
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Discussion
Our experiments showed that culture of mouse iPS cells on type IV collagen-coated
6-well plates in KCM, either supplemented with BMP-4 and RA or not supplemented
with these compounds, resulted in differentiation of the cells into stratified epithelial
stem/progenitor cells as confirmed by various methods. This study showed the
progressive loss of expression of the pluripotency gene markers Oct3/4 and Nanog,
followed by the induction and maintenance of p63 and CK14. These cells have
characteristics similar to those of stratified epithelial stem/progenitor cells.
Immunofluorescence staining and real-time RT-PCR analysis over a time course
revealed several distinct steps in epithelial lineage development. The first step was
marked by loss of Oct3/4 and Nanog expression, and gain of CK18 expression. The
presence of p63 in the absence of CK14 defines the second step. The third step was
marked by the appearance of CK14 in p63-containing cells. This finding seems
consistent with what is known about the appearance of p63 in mouse embryogenesis,
as recent studies have found p63 as early as stage E9.5, whereas CK5 (partner of
CK14) dose not appear until E15.5.14)-16)
In several studies, differentiation was induced in the mouse ES cells by culturing
them by the addition of growth factors.22) In particular, the growth factors (epidermal
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growth factor (EGF), BMP-4, RA, and basic fibroblast growth factor (bFGF)) were
shown to activate ectodermal cells.22)
EGF is included in KCM. Type IV collagen is the basic structural component of all
basement membranes.23) Therefore, in this study we attempted to establish a simple
method for directed differentiation of mouse ES and iPS cells into stratified epithelial
stem/progenitor cells by culturing on type IV collagen-coated 6-well plates in KCM. As
a result, stratified epithelial stem/progenitor cells were successfully induced from
mouse ES and iPS cells without using feeder layer support.
We also demonstrated that mouse ES and iPS cells effectively differentiated into
stratified epithelial stem/progenitor cells following the addition of BMP-4 and RA. This
finding suggests that BMP-4 and RA promote mouse ES and iPS cell commitment to
the epithelial lineage and provide a survival advantage to epithelial cells over other
cell types. BMP-4 plays a critical role in ectodermal commitment and directly activates
Np63, which is not required for ectodermal fate determination, but it enhances the
proliferation and epidermal commitment of ES-derived ectodermal cells. An increase
in Np63 directly activates the CK14 promoter.14)-16), 21) In contrast, RA is a potent
regulator of cell proliferation and differentiation and early addition of RA disrupts
neural differentiation and induces upregulation of Np63.22), 24) Therefore, we propose
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that a synergistic effect was observed when BMP-4 was combined with RA.
Nanog-iPS cell line (iPS-MEF-Ng-38D-2) are similar to ES cell line (RF8) in
morphology, proliferation, teratoma formation, gene expression and competency for
adult chimeras.4) Using our methods, the differentiation efficiency of stratified
epithelial stem/progenitor cells from mouse iPS cell cultures was not different from
that of mouse ES cell cultures. Therefore, in addition to their similarity in pluripotency,
epithelial differentiation methods using defined factors for ES cells could be applicable
to iPS cells, although further research is required to characterize the function of
induced stratified epithelial stem/progenitor cells.
However, in several studies showed that there was variability in the response of a
particular iPS cell line to the induction protocol.25) It will be interesting in the future to
directly compare the several iPS cells with this protocols to determine whether
particular iPS cell lines might be better suited to our protocols of direct differentiation.
A risk of tumor formation by contaminating undifferentiated cells is not resolved.3), 4)
All of the variables affecting safety must be strictly evaluated before cell therapies
based on iPS cells advanced to the clinic. Thus, to prevent tumor formation,
establishment of purification methods will be requisite.
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We expect that the stratified epithelial stem/progenitor cells derived from mouse ES
and iPS cells are able to be purified using fluorescence activated cell sorting (FACS).
Stage specific embryonic antigens (SSEAs) were originally identified by monoclonal
antibodies recognizing defined carbohydrate epitopes associated with lacto- and
globo-series glycolipids. They are often used as markers for stem cell
differentiation.26) SSEA-1 is expressed on mouse ES and iPS cells.27) The expression
of SSEA-1 decreases with the differentiation of mouse ES and iPS cells.28) On the
contrary, CK14 is expressed during differentiation of mouse ES and iPS cells into
stratified epithelial stem/progenitor cells. Therefore, we suppose that undifferentiated
cells and ES- and iPS-cell-derived stratified epithelial stem/progenitor cells could be
distinguished with these markers.
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Conclusions
This article describes, for the first time, the differentiation of mouse iPS cells to
stratified epithelial stem/progenitor cells. The in vitro differentiation of iPS cells not
only provides a powerful model for understanding the cellular and molecular
mechanisms of epithelial lineage differentiation, it also demonstrates the capacity of
ES and iPS cells to provide a source of epithelial cells for tissue engineering
applications in vitro and in vivo.
17
Acknowledgements
We thank Dr. S. Yamanaka (Kyoto University) for kindly providing Nanog-iPS cells.
This work was supported by the Japan Science and Technology Agency (JST)
Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports,
Science and Technology of Japan.
18
References
1. Evans MJ, Kaufman MH : Establishment in culture of pluripotential cells from
mouse embryos. Nature 1981;292:154-156
2. Yamanaka S : Strategies and new developments in the generation of
patient-specific pluripotent stem cells. Cell Stem Cell 2007;1:39-49
3. Takahashi K, Yamanaka S : Induction of pluripotent stem cells from mouse
embryonic and adult fibroblast cultures by defined factors. Cell 2006;126:663-676
4. Okita K, Ichisaka T, Yamanaka S : Generation of germline-competent induced
pluripotent stem cells. Nature 2007;448:313-17
5. Takahashi K, Tanabe K, Ohnuki M, et al : Induction of pluripotent stem cells from
adult human fibroblasts by defined factors. Cell 2007;131:861-72
6. Senju S, Haruta M, Matsunaga Y, et al : Characterization of dendritic cells and
macrophages generated by directed differentiation from mouse induced
pluripotent stem cells. Stem Cells 2009;27:1021-1031
7. Narazaki G, Uosaki H, Teranishi M, et al : Directed and systematic differentiation
of cardiovascular cells from mouse induced pluripotent stem cells. Circulation
2008;118:498-506
8. Mauritz C, Schwanke K, Reppel M, et al : Generation of functional murine cardiac
myocytes from induced pluripotent stem cells. Circulation 2008;118:507-517
19
9. Zhang J, Wilson GF, Soerens AG, et al : Functional cardiomyocytes derived from
human induced pluripotent stem cells. Circ Res 2009;104:e30-e41
10. Taura D, Sone M, Homma K, et al : Induction and isolation of vascular cells from
human induced pluripotent stem cells--brief report. Arterioscler Thromb Vasc Biol
2009;29:1100-1103
11. Karumbayaram S, Novitch BG, Patterson M, et al : Directed differentiation of
human-induced pluripotent stem cells generates active motor neurons. Stem
Cells 2009;27:806-811
12. Zhang D, Jiang W, Liu M, et al. Highly efficient differentiation of human ES cells
and iPS cells into mature pancreatic insulin-producing cells. Cell Res
2009;19:429-438
13. McMahon AP, Bradley A : The Wnt-1 (int-1) proto-oncogene is required for
development of a large region of the mouse brain. Cell 1990;62:1073-1085
14. Rufini A, Weil M, McKeon F, et al : p63 protein is essential for the embryonic
development of vibrissae and teeth. Biochem Biophys Res Commun
2006;340:737-741
15. Senoo M, Pinto F, Crum CP, et al : p63 Is essential for the proliferative potential of
stem cells in stratified epithelia. Cell 2007;129:523-536
20
16. Romano RA, Ortt K, Birkaya B, et al : An active role of the DeltaN isoform of p63
in regulating basal keratin genes K5 and K14 and directing epidermal cell fate.
PLoS One 2009;4:e5623
17. Moll R, Franke WW, Schiller DL, et al : The catalog of human cytokeratins:
patterns of expression in normal epithelia, tumors and cultured cells. Cell
1982;31:11-24
18. Nichols J, Zevnik B, Anastassiadis K, et al : Formation of pluripotent stem cells in
the mammalian embryo depends on the POU transcription factor Oct4. Cell
1998;95:379-391
19. Chambers I, Colby D, Robertson M, et al : Functional expression cloning of Nanog,
a pluripotency sustaining factor in embryonic stem cells. Cell 2003;113:643-655
20. Mitsui K, Tokuzawa Y, Itoh H, et al : The homeoprotein Nanog is required for
maintenance of pluripotency in mouse epiblast and ES cells. Cell
2003;113:631-642
21. Aberdam D, Gambaro K, Rostagno P, et al : Key role of p63 in BMP-4-induced
epidermal commitment of embryonic stem cells. Cell Cycle 2007;6:291-294
22. Schuldiner M, Yanuka O, Itskovitz-Eldor J, et al : Effects of eight growth factors on
the differentiation of cells derived from human embryonic stem cells. Proc Natl
Acad Sci U S A 2000;97:11307-11312
21
23. Cleutjens JP, Havenith MG, Kasper M, et al : Absence of type IV collagen in the
centre of the corneal epithelial basement membrane. Histochem J
1990;22:688-694
24. Metallo CM, Ji L, de Pablo JJ, et al : Retinoic acid and bone morphogenetic
protein signaling synergize to efficiently direct epithelial differentiation of human
embryonic stem cells. Stem Cells 2008;26:372-380
25. Lamba DA, McUsic A, Hirata RK, et al : Generation, purification and
transplantation of photoreceptors derived from human induced pluripotent stem
cells. PLoS One 2010;5:e8763
26. Cui L, Johkura K, Yue F, et al : Spatial distribution and initial changes of SSEA-1
and other cell adhesion-related molecules on mouse embryonic stem cells before
and during differentiation. J. Histochem. Cytochem 2004;52:1447–1457
27. Stadtfeld M, Maherali N, Breault DT, et al : Defining molecular cornerstones
during fibroblast to iPS cell reprogramming in mouse. Cell Stem Cell
2008;2:230-40
28. Yue W, Pi QM, Zhang WJ, et al : PECAM-1, SSEA-1 and Flk-1 mark distinct
populations of mouse embryonic stem cells during differentiation towards
hematopoietic/endothelial cells. Stem Cells Dev 2010; [Epub ahead of print]
22
Figure Legends
Figure 1. Schematic representation of the protocol design for differentiation of mouse
ES and iPS cells into epithelial progenitor cells.
Undifferentiated mouse ES and iPS cells were induced to differentiate by three
methods: (A) culture in KCM, (B) culture in KCM with exposure to 0.5 nM BMP-4 on
different days of culture, or (C) culture with 0.5 nM BMP-4 and 1 M RA in the
undifferentiated state, then culture in KCM with 0.5 nM BMP-4 added on different days
of culture. The first induction day was defined as day 0. Arrowheads indicate steps at
which 0.5 nM BMP-4 was added.
Figure 2. Time course study of the appearance of mouse ES and iPS cell colonies
with p63 and CK14 immunoreactivities in different culture conditions.
Undifferentiated mouse ES and iPS cells were induced to differentiate by three
methods: (1) culture in KCM, (2) culture in KCM with exposure to 0.5 nM BMP-4 on
different days of culture, and (3) treatment with 0.5 nM BMP-4 and 1 M RA in the
undifferentiated state, then culture in KCM with 0.5 nM BMP-4 added on different days
of culture. The percentage of p63-positive (A, C) or CK14-positive (B, D) colonies in
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different culture conditions of mouse ES (C, D) and iPS (A, B) cells. The first induction
day was defined as day 0. The graphs show the mean ± SE of 3 independent samples.
* indicates a p-value < 0.05.
Figure 3. Direct differentiation of epithelial progenitor cells from mouse ES and iPS
cells.
Immunofluorescence staining of mouse iPS cells cultured on type IV collagen in
KCM in the (a-c) absence or (d-f) presence of BMP-4 or (g-i) BMP-4 and RA
harvested on (3A) day 14 or (3B) day 21 using anti-p63 and anti-CK14 antibodies. (j-l)
Immunofluorescence staining of mouse ES-cell-derived cells cultured on type IV
collagen in KCM supplemented with BMP-4 and RA harvested on (3A) day 14 or (3B)
day 21 using anti-p63 and anti-CK14 antibodies.
(a,d,g,j) p63 (red), (b,e,h,k) CK14 (green), (c,f,i,l) p63/CK14 merge. p63 expression
was detected in the nuclei and CK14 expression was detected in the cytoplasm. Most
of the CK14 expression corresponded with p63 expression. Nuclei were labeled with
Hoechst 33342 (blue). The scale bar represents 100 µm.
Figure 4. Quantification of non-differentiated and epithelial differentiation markers in
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mouse ES- and iPS-cell-derived cells.
Quantitative real-time RT-PCR of the following marker genes from mouse ES- and
iPS-cell-derived cells was performed: (4A-a, 4B-a) Oct3/4, (4A-b, 4B-b) Nanog, (4A-c,
4B-c) CK18, (4A-d, 4B-d) Np63 and (4A-e, 4B-e) CK14. The first induction day was
defined as day 0. The normalized gene expression: glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) ratio in each sample is shown on the y-axis. The
pluripotency markers Oct3/4 and Nanog were downregulated during the differentiation
of mouse ES and iPS cells. In contrast, the epithelial differentiation markers CK18,
Np63 and CK14 were upregulated during the differentiation of mouse ES and iPS
cells. The graphs show the mean ± SE of 3 independent samples. * indicates a
p-value < 0.05 and ** indicates a p-value < 0.001.
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